HP EPS BEATS ESTIMATES; STOCK FALLS BELOW MA5

August 23, 2019

HP Inc.’s stock is currently trading at 17.57-lower by 7.18% as compared to the previous closing price. In the pre-market trading session, the stock was trading lower by 8.87%. The stock has pared some of its earlier losses after the opening bell. The company reported its earnings after the market close on Thursday. HP generated

Read More  

TESLA’S STOCKS RISE ABOVE MA5 AFTER REPORT OF INVESTMENT INTEREST BY VOLKSWAGEN

August 22, 2019

Tesla’s stock is currently trading at 223.88-higher by 1.38% as compared to the previous closing price. In the pre-market trading session, the stock was trading higher by 2.30%. The stock has pared some of its earlier gains after the opening bell. Tesla stocks surged today after Germany’s business publication Manager Magazin reported that Volkswagen CEO

Read More  

TARGET Q2 PROFIT TOPS EXPECTATIONS, STOCK ABOVE ALL MAs

August 21, 2019

Target Corp. is currently trading at 102.22-higher by 19.46% as compared to the previous closing price. In the pre-market trading session, the stock was trading higher by 17%. The stock has continued gaining after the opening bell. The company reported its fiscal second-quarter results before the market open on Wednesday. Target generated an EPS of

Read More  

HOME DEPOT BEATS Q2 EARNINGS EXPECTATIONS, STOCK RISES

August 20, 2019

Home Depot is currently trading at 217.35-higher by 4.53% as compared to the previous closing price. In the pre-market trading session, the stock was trading higher by 2.51%. The stock has continued gaining after the opening bell. The company reported its fiscal second-quarter results before the market open on Tuesday. The home improvement retailer’s quarterly

Read More  

AMGEN STOCKS RISE DESPITE RATING DOWNGRADE

August 19, 2019

Amgen Inc. is currently trading at 205.75-higher by 0.85% as compared to the previous closing price. In the pre-market trading session, the stock was trading higher by 0.73%. The stock has continued gaining after the opening bell. Mizuho Securities downgraded the rating of the biopharmaceutical company to neutral from buy. The investment bank said the

Read More